Phase II Dose-Randomized Study of Sunvozertinib in Platinum-Pretreated Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor Exon 20 Insertion Mutations (WU-KONG1B).

Journal:

Journal of Clinical Oncology

Published:

2025-09-10

DOI:

10.1200/jco-25-00788

Affiliations:

50

Authors:

83

Go to article

Institutions	Authors	Share
Hospital de Jerez de la Frontera, Spain	1.000000	0.02
IRCCS Physiotherapy Institutes Hospitallers (IFO), Italy	1.000000	0.02
The University of Texas MD Anderson Cancer Center, United States of America (USA)	1.000000	0.02
Jinan Central Hospital, China	1.000000	0.02
Taipei Veterans General Hospital (TPEVGH), Taiwan	1.000000	0.02
Children's Hospital, CHU-Toulouse, France	1.000000	0.02
La Paz University Hospital, UAM, Spain	1.000000	0.02
Hospital Timone, France	1.000000	0.02
Peter MacCallum Cancer Centre (Peter Mac), Australia	1.000000	0.02
Zhongshan Hospital, Fudan University, China	1.000000	0.02
Southern Medical Day Care Centre, Australia	1.000000	0.02
Biomedical Research Institute of Girona (IDIBGI), Spain	1.000000	0.02
Santa Maria delle Croci Hospital, Italy	1.000000	0.02
Asan Medical Center (AMC), South Korea	1.000000	0.02
National Taiwan University Hospital (NTUH), Taiwan	1.000000	0.02
The Ohio State University (OSU), United States of America (USA)	1.000000	0.02
Tianjin Medical University Cancer Institute and Hospital, TMU, China	1.000000	0.02
Hospital de la Santa Creu i Sant Pau, Spain	1.000000	0.02
Moores Cancer Center, United States of America (USA)	1.000000	0.02
Dana-Farber Cancer Institute (DFCI), United States of America (USA)	1.000000	0.02
H. Lee Moffitt Cancer Center & Research Institute, United States of America (USA)	1.000000	0.02
Clínica Universidad de Navarra (CUN), UNAV, Spain	1.000000	0.02
Taichung Veterans General Hospital, Taiwan	1.000000	0.02
Beijing Tuberculosis and Thoracic Tumor Institute / Beijing Chest Hospital, Capital Medical University, China	1.000000	0.02
Dizal Pharmaceutical Co., Ltd., China	1.000000	0.02
Beijing Cancer Hospital / School of Oncology, PKUHSC, China	1.000000	0.02
Centro Médico Austral, Argentina	1.000000	0.02
Hospital Universitario 12 de Octubre, Spain	1.000000	0.02
Vall d'Hebron University Hospital (HUVH), ICS, Spain	1.000000	0.02
Hospital Regional Universitario de Málaga, Spain	1.000000	0.02
St. Vincent's Hospital, South Korea	1.000000	0.02
First Affiliated Hospital, ZZU, China	1.000000	0.02
Institute of Cancer Research (ICO), France	1.000000	0.02
Centre Georges-François Leclerc (CGFL), France	1.000000	0.02
National Cancer Center (NCC), South Korea	1.000000	0.02
Princess Margaret Cancer Centre, U of T, Canada	1.000000	0.02
Taizhou Hospital of Zhejiang Province, China	1.000000	0.02
Peking Union Medical College Hospital (PUMCH), China	1.000000	0.02
Institute Gustave-Roussy (IGR), France	1.000000	0.02
Ospedale di Parma, Italy	1.000000	0.02
Careggi University Hospital (AOUC), UNIFI, Italy	1.000000	0.02
Seoul National University Bundang Hospital (SNUBH), South Korea	1.000000	0.02
NYU Laura and Isaac Perlmutter Cancer Center, United States of America (USA)	1.000000	0.02
Zhejiang Cancer Hospital (ZJCH), China	1.000000	0.02
IRCCS National Cancer Institute (INT) Aviano, Italy	1.000000	0.02
Bichat-Claude Bernard Hospital, France	1.000000	0.02
Azienda Ospedaliero - Universitaria "Policlinico - Vittorio Emanuele", Italy	1.000000	0.02
Catalan Institute of Oncology (ICO), Spain	0.500000	0.01
Germans Trias i Pujol University Hospital (HUGTP), ICS, Spain	0.500000	0.01

Interested in Oncology and Carcinogenesis?